These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17969455)
21. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889 [TBL] [Abstract][Full Text] [Related]
22. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245 [TBL] [Abstract][Full Text] [Related]
23. Innate immune responses to LCMV infections: natural killer cells and cytokines. Biron CA; Nguyen KB; Pien GC Curr Top Microbiol Immunol; 2002; 263():7-27. PubMed ID: 11987821 [TBL] [Abstract][Full Text] [Related]
24. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594 [TBL] [Abstract][Full Text] [Related]
25. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Von Herrath MG; Coon B; Oldstone MB Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248 [TBL] [Abstract][Full Text] [Related]
26. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. Pien GC; Biron CA J Immunol; 2000 Jan; 164(2):994-1001. PubMed ID: 10623849 [TBL] [Abstract][Full Text] [Related]
27. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Xu HC; Grusdat M; Pandyra AA; Polz R; Huang J; Sharma P; Deenen R; Köhrer K; Rahbar R; Diefenbach A; Gibbert K; Löhning M; Höcker L; Waibler Z; Häussinger D; Mak TW; Ohashi PS; Lang KS; Lang PA Immunity; 2014 Jun; 40(6):949-60. PubMed ID: 24909887 [TBL] [Abstract][Full Text] [Related]
28. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266 [TBL] [Abstract][Full Text] [Related]
30. Type I interferons promote cross-priming: more functions for old cytokines. Beignon AS; Skoberne M; Bhardwaj N Nat Immunol; 2003 Oct; 4(10):939-41. PubMed ID: 14515123 [No Abstract] [Full Text] [Related]
32. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. Bukowski JF; Welsh RM J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125 [TBL] [Abstract][Full Text] [Related]
33. IL-12 is not required for induction of type 1 cytokine responses in viral infections. Oxenius A; Karrer U; Zinkernagel RM; Hengartner H J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721 [TBL] [Abstract][Full Text] [Related]
34. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus. Leist TP; Aguet M; Hässig M; Pevear DC; Pfau CJ; Zinkernagel RM J Gen Virol; 1987 Aug; 68 ( Pt 8)():2213-8. PubMed ID: 3612089 [TBL] [Abstract][Full Text] [Related]
35. Translating insights from persistent LCMV infection into anti-HIV immunity. Wilson EB; Brooks DG Immunol Res; 2010 Dec; 48(1-3):3-13. PubMed ID: 20725865 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13. Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118 [TBL] [Abstract][Full Text] [Related]
37. Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection. Lewis GM; Macal M; Hesser CR; Zuñiga EI J Virol; 2015 Mar; 89(6):3343-55. PubMed ID: 25589641 [TBL] [Abstract][Full Text] [Related]
38. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. Ousman SS; Wang J; Campbell IL J Virol; 2005 Jun; 79(12):7514-27. PubMed ID: 15919906 [TBL] [Abstract][Full Text] [Related]
39. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. Orange JS; Biron CA J Immunol; 1996 Feb; 156(3):1138-42. PubMed ID: 8557990 [TBL] [Abstract][Full Text] [Related]
40. A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. Doughty L; Nguyen K; Durbin J; Biron C J Immunol; 2001 Feb; 166(4):2658-64. PubMed ID: 11160329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]